BlackRock Health Sciences Trust Cash Flow Conversion Efficiency

Latest as of December 2025: -0.017x

BlackRock Health Sciences Trust cash flow conversion efficiency. Based on the latest financial reports, BlackRock Health Sciences Trust (BME) has a cash flow conversion efficiency ratio of -0.017x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.45 Million) by net assets ($568.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BlackRock Health Sciences Trust (2006–2025)

Cash flow conversion efficiency of BlackRock Health Sciences Trust from 2006 to 2025. This chart illustrates how BlackRock Health Sciences Trust's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BlackRock Health Sciences Trust share price for real-time trading data and today's change.

BlackRock Health Sciences Trust Cash Flow Conversion Ratio Explained

BlackRock Health Sciences Trust cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BlackRock Health Sciences Trust Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BlackRock Health Sciences Trust ranked by their cash flow conversion efficiency. Also see BME stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Hainan Expressway Co Ltd
SHE:000886
-0.027x
Wesure Global Tech Ltd
TA:WESR
-0.026x
Giti Tire Corp
SHG:600182
0.076x
Voltalia SA
PA:VLTSA
0.078x
Shandong Xinneng Taishan Power Generation Co Ltd
SHE:000720
-0.057x
Ibotta, Inc.
NYSE:IBTA
0.066x
Allied Electronics Corporation Ltd
JSE:AEL
0.163x
China Building Material
SHG:603060
0.043x

Annual Cash Flow Conversion Efficiency for BlackRock Health Sciences Trust (2006–2025)

The table below shows the annual cash flow conversion efficiency of BlackRock Health Sciences Trust from 2006 to 2025. Review BME free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $568.30 Million $-4.35 Million -0.008x -108.98%
2024-12-31 $768.57 Million $65.52 Million 0.085x +56.59%
2023-12-31 $588.14 Million $32.02 Million 0.054x +3838.40%
2022-12-31 $600.20 Million $-874.04K -0.001x +95.77%
2021-12-31 $625.77 Million $-21.56 Million -0.034x +2.82%
2020-12-31 $545.94 Million $-19.35 Million -0.035x -311.19%
2019-12-31 $1.64 Billion $-14.10 Million -0.009x -248.27%
2018-12-31 $352.67 Million $2.05 Million 0.006x +264.94%
2017-12-31 $331.86 Million $-1.17 Million -0.004x -147.50%
2016-12-31 $270.69 Million $2.01 Million 0.007x +72.61%
2015-12-31 $297.53 Million $1.28 Million 0.004x -98.87%
2014-12-31 $303.10 Million $115.30 Million 0.380x +485.01%
2013-12-31 $270.16 Million $17.57 Million 0.065x -13.63%
2012-12-31 $218.38 Million $16.44 Million 0.075x +138.74%
2008-12-31 $179.64 Million $-34.91 Million -0.194x -222.24%
2007-12-31 $230.28 Million $36.61 Million 0.159x +34.62%
2006-12-31 $208.15 Million $24.58 Million 0.118x --

About BlackRock Health Sciences Trust

NYSE:BME USA Asset Management
Market Cap
$607.17 Million
Market Cap Rank
#11238 Global
#2923 in USA
Share Price
$46.98
Change (1 day)
+0.23%
52-Week Range
$37.67 - $46.98
All Time High
$46.98
About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or d… Read more